Insights on the efficacy and safety of PCSK-9 inhibitor in Taiwanese patients
J Chin Med Assoc
.
2019 Nov;82(11):809-810.
doi: 10.1097/JCMA.0000000000000183.
Author
Harn-Shen Chen
1
Affiliation
1
Division of Endocrinology and Metabolism, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan, ROC.
PMID:
31469687
DOI:
10.1097/JCMA.0000000000000183
No abstract available
Publication types
Editorial
Comment
MeSH terms
Antibodies, Monoclonal*
Antibodies, Monoclonal, Humanized
Humans
Republic of Korea
Taiwan
Substances
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
alirocumab